|
Dr. Jay Luly joined Enanta in July 2003, bringing over 20 years of experience in large pharma, mature biopharmaceutical, early-stage biotech, and life science venture capital environments. In March 2002, he joined Oxford Bioscience Partners as an Entrepreneur in Residence. Prior to joining Oxford, Dr. Luly held the positions of Senior Vice President, R&D Operations and Senior Vice President, Discovery Strategy and Operations at Millennium Pharmaceuticals, following the Company's merger with LeukoSite, Inc., where he served as Senior Vice President, Drug Discovery and Pre-Clinical Development. Prior to joining LeukoSite, he held a number of senior drug discovery positions at Abbott Laboratories from 1983 to 1997. His R&D efforts have resulted in several therapeutics reaching clinical development, and he is an inventor on over 50 issued U.S. patents and has authored over 150 scientific publications, abstracts, and review articles. Dr. Luly earned a B.S. with highest distinction from the University of Illinois, Urbana/Champaign and a Ph.D. in synthetic organic chemistry from the University of California, Berkeley | 